Navigating Coverage and Cost: What Pharmacists Need to Know About Access to Non-Hormonal VMS Therapies

In 'Navigating Coverage and Cost: What Pharmacists Need to Know About Access to Non-Hormonal VMS Therapies,' our panel of experts delve into the following question:

1. What are you seeing in terms of insurance coverage for non-hormonal VMS therapies? Are there any barriers that you are seeing to coverage approval?

Led by the moderator, the panelists examined the current insurance coverage landscape for fezolinetant and elinzanetant, noting that coverage success has been reasonably favorable thus far, with manufacturers actively working to ensure affordability through copay cards, bridge programs, and patient assistance programs, which allows prescriptions to be sent directly through the platform at a flat rate. The discussion highlighted that prior authorization remains one of the most significant real-world barriers to timely access, with patients potentially facing treatment delays while approvals are processed, underscoring the important role pharmacists play in proactively managing prior authorization submissions, troubleshooting denials in real time, and connecting patients with manufacturer resources before they leave the pharmacy without their medication. The panelists also emphasized that the coverage and access landscape for these newer agents is evolving rapidly, making it essential for pharmacists to stay current on available programs and resources so they can serve as effective navigators for patients who encounter affordability or coverage challenges at the point of dispensing.

Throughout the conversation, the experts provide a comprehensive reflection on the field and the factors that may shape how clinicians approach care moving forward.

Our next and final episode, 'Menopause is Everyone's Business: Final Reflections on VMS Treatment and Pharmacist Empowerment,' further explores vasomotor symptoms and menopause, highlighting the panelists' closing thoughts on the evolving non-hormonal treatment landscape, the critical role pharmacists are positioned to play in closing the menopause care gap, and a call to action for pharmacists at every stage of their career to get curious, get educated, and get involved.